Maryam
Karachi, Sindh, 7523, Pakistan
NCT Number: NCT07385040
Hemodymanic stress response to direct laryngoscopy and endotracheal intubation is a known phenomenon that occur in almost every patient undergoing general anesthesia before surgical procedure. This response leads to sudden rise in heart rate and blood pressure which may cause serious complications in compromised patients having cardiovascular diseases. There are certain drugs which are used to blunt this response and to prevent the life threatening complications. Intravenous Lignocain is commonly used drug to blunt the laryngoscopic response in our setup. Intravenous Dexmedetomidine is a newer and rarely used drug to prevent stress response to direct laryngoscopy and endotracheal intubation. This study aims to compare the efficacy of both the drugs to provide better control of complications like Arrythmias, stroke and cardiovascular instability.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 2 / Phase 3
Karachi, Sindh, 7523, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients undergoing general anesthesia for any elective surgery Having ASA 1 or 2 Having mallapatti 1 or 2 Having BMI in between 18-30 kg/m2
Exclusion criteria
Lack of consent Anticipated difficult airway Pregnancy Sensitivity to either drug
Dexmedetomidine infusion with dose of 10mics/kg given 10min before induction
Intravenous ligoncain 1.5mg/kg given 90sec before induction.
Time frame: 1 minute and 3 minute after endotracheal intubation
Rise in Heart rate and mean arterial pressure
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Other
Comparison of Intravenous Lignocain and Intravenous Dexmedetomidine for Attenuation of Hemodynamic Stress Response to Direct Laryngoscopy and Endotracheal Intubation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258628
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07097441
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Karachi, Sindh, Pakistan
View Trial DetailsNCT00644644
Arrhythmias, Cardiac, Bradycardia
Nashville, Tennessee, United States
View Trial DetailsNCT02608775
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Jette, Belgium
View Trial Details